Valion Bio Issues $250K Series Securities Under Its April 29, 2025 Securities Purchase Agreement With Undisclosed Investor

Benzinga Newsdesk www.benzinga.com Neutral 93.3%

Neg 0% Neu 93.3% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/1787740/000168316826004956/valion_8k.htm

Comments

No comments yet. Be the first!